 |
|
|||||||||||
|
||||||||||||
Fish Oil and the Reduction of Myocardial Infarction in Women
The title of this study is Effects of supplementation with fish oil derived n-3 fatty acids and -linolenic acid on circulating plasma lipids and fatty acid profiles in women. The researchers were Maggie Laidlaw and Bruce J Holub. The research was conducted at he Department of Human Biology and Nutritional Sciences, University of Guelph, Canada. The results were published in the Nutrition in Clinical Practice Journal in August of 2006.
The study background was that Eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and -linolenic acid (GLA) has lipid-modifying and anti-inflammatory properties. The effects of supplement mixtures of these fatty acids on plasma lipids and the fatty acid compositions of serum phospholipids have received little attention. The objective was to determine the effects of different levels of GLA supplementation together with a constant intake of EPA plus DHA on the triacylglycerol-lowering effect of EPA plus DHA alone and on the fatty acid patterns (eicosanoid precursors) of serum phospholipids.
The study design was thirty-one women were assigned to 1 of 4 groups, equalized on the basis of their fasting triacylglycerol concentrations. They received supplements providing 4 g EPA+DHA (4:0, EPA+DHA:GLA; control group), 4 g EPA+DHA plus 1 g GLA (4:1), 2 g GLA (4:2), or 4 g GLA (4:4) daily for 28 d. Plasma lipids and fatty acids of serum phospholipids were measured on days 0 and 28. Plasma triacylglycerol concentrations were significantly lower on day 28 than on day 0 in the 4:0, 4:1, and 4:2 groups. LDL cholesterol decreased significantly (by 11.3%) in the 4:2 group. Dihomo--linolenic acid increased significantly in serum phospholipids only in the 4:2 and 4:4 groups; however, total n-3 fatty acids increased in all 4 groups.
The researchers conclusions were a mixture of 4 g EPA+DHA and 2 g GLA favorably altered blood lipid and fatty acid profiles in healthy women. On the basis of calculated PROCAM values, the 4:2 group was estimated to have a 43% reduction in the 10-y risk of myocardial infarctionOmega 3 fish oils Pure EPA is available exclusively from mind 1st.
|
|
Mind1st Information Line: 01772 883950
mind | whats in Pure EPA | omega 3 info | fish oil capsules | flaxseed fish oil | omega 3 fish oil | pure EPA | EPA | fish oils and how to grade them | fish oil supplements | essential fatty acids | omega 3 fatty acid | eicosapentaenoic acid | fish oils | pregnancy | pharmaceutical grade fish oil | Epa fish oil | Omega 3 fish oil EPA and DHA | IBS symptom relief | borage oil | Fish oil cholesterol | fish oil pill tablet | fish oil vitamin | fish oil side effects | benefit of fish oil | vegepa | omega 3 fish oil capsule | dosage | vitamin e | ADHD | arthritis | pregnancy| depression | weight loss | children | bipolar | fatty acid | benefit of fish oil | health benefits | fischöl | acne | DHA | fish oil and PMS | diabetes | allergy | heart disease | deep sea fish | ADD | ultra refined fish oil | concentrate purity | information | supplements and mercury m | anxiety | blood pressure | healthy skin | OCD | liver disease | fish oil dietary supplement | omega 3 6 9 | Request a link | weight loss programme
© 2008 www.mind1st.co.uk fish
oil
A Nurank Corp company www.nurankcorp.com